Celldex Therapeutics (CLDX) Return on Sales Growth (3y) (2013 - 2026)
Celldex Therapeutics (CLDX) Return on Sales Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 0.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Celldex Therapeutics | 1.72 Mn | 1.72 Mn | -1.44 Mn | -5,694.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5,694.00 |
| Dec 31, 2025 | -890.00 |
| Sep 30, 2025 | -140.00 |
| Jun 30, 2025 | 133.00 |
| Mar 31, 2025 | 42.00 |
| Dec 31, 2024 | -230.00 |
| Sep 30, 2024 | 118.00 |
| Jun 30, 2024 | -15.00 |
| Mar 31, 2024 | -247.00 |
| Dec 31, 2023 | -88.00 |
| Sep 30, 2023 | -6.00 |
| Jun 30, 2023 | -79.00 |
| Mar 31, 2023 | -26.00 |
| Dec 31, 2022 | -5.00 |
| Sep 30, 2022 | -45.00 |
| Jun 30, 2022 | -204.00 |
| Mar 31, 2022 | -120.00 |
| Dec 31, 2021 | -58.00 |
| Sep 30, 2021 | -126.00 |
| Jun 30, 2021 | 2.00 |